Elevated serum tryptase levels identify a subset of patients with a myeloproliferative variant of idiopathic hypereosinophilic syndrome associated with tissue fibrosis, poor prognosis, and imatinib responsiveness

Blood

Volumn 101, Issue 12, 2003, Pages 4660-4666

  Klion, Amy D ^a   Noel, Pierre ^b   Akin, Cem ^b   Law, Melissa A ^b   Gilliland, D Gary ^b   Cools, Jan ^b   Metcalfe, Dean D ^b   Nutman, Thomas B ^b  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYANOCOBALAMIN; IMATINIB; INTERLEUKIN 2 RECEPTOR; ISOPROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; STEM CELL FACTOR; TRYPTASE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW BIOPSY; CAUSE OF DEATH; CELL AGGREGATION; CELL ULTRASTRUCTURE; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE MARKER; DRUG EFFECT; EOSINOPHILIA; FEMALE; FIBROSIS; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPEREOSINOPHILIC SYNDROME; IDIOPATHIC DISEASE; MALE; MAST CELL; MASTOCYTOSIS; MYELOPROLIFERATIVE DISORDER; PRIORITY JOURNAL; PROGNOSIS; SPLENOMEGALY; TREATMENT OUTCOME; VITAMIN BLOOD LEVEL;

EID: 0038792233     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2003-01-0006     Document Type: Article

References (35)

1. Chusid MJ, David DC, West BC, Wolff SM. The hypereosinophilic syndrome: analysis of fourteen cases with review of the literature. Medicine. 1975;54:1-27.
2. Weller PF, Bubley GJ. The idiopathic hypereosinophilic syndrome. Blood. 1994;83:2759-2779.
3. Assa'ad AH, Spicer RL, Nelson DP, Zimmerman N, Rothenberg ME. Hypereosinophilic syndromes. Chem Immunol. 2000;76:208-229.
4. Chang H, Leong K, Koh D, Lee S. Clonality of isolated eosinophils in the hypereosinophilic syndrome. Blood. 1999;93:1651-1657.
5. Simon HU, Plotz SG, Dummer R, Blaser K. Abnormal clones of T cells producing interleukin-5 in idiopathic eosinophilia. N Engl J Med. 1999;341:1112-1120.
6. Roufosse F, Schandene L, Sibille C, et al. Clonal Th2 lymphocytes in patients with the idiopathic hypereosinophilic syndrome. Br J Haematol. 2000;109:540-548.
7. Cools J, DeAngelo DJ, Gotlib J, et al. A novel tyrosine kinase created by the fusion of the PDGFRA and FIP1L1 genes is a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome. N Engl J Med. 2003;348:1201-1214.
8. Parrillo JE, Fauci AS, Wolff SM. Therapy of the hypereosinophilic syndrome. Ann Intern Med. 1978;89:167-172.
9. McCarthy KP, Sloane JP, Kabarowski JH, Matutes E, Wiedemann LM. A simplified method of detection of clonal rearrangements of the T-cell receptor-gamma chain gene. Diagn Mol Pathol. 1992;1:173-179.
10. Yavuz AS, Lipsky PE, Yavuz S, Metcalfe DD, Akin C. Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene. Blood. 2002;100:661-665.
11. Akin C, Kirshenbaum AS, Semere A, Worobec AS, Scott LM, Metcalfe DD. Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in myelomonocytic cells, T cells, and B cells from patients with mastocytosis. Exp Hematol. 2000;28:140-147.
12. Escribano L, Orfao A, Diaz-Agustin B, et al. Indolent systemic mast cell disease in adults: immunophenotypic characterization of bone marrow mast cells and its diagnostic implications. Blood. 1998;91:2731-2736.
13. Gilbert HS, Krauss S, Pasternack B, Herbert V, Wasserman LR. Serum vitamin B12 content and unsaturated vitamin B12-binding capacity in myeloproliferative disease: value in differential diagnosis and as indicators of disease activity. Ann Intern Med. 1969;71:719-729.
14. Zittoun J, Farcet JP, Marquet J, Sultan C, Zittoum R. Cobalamin (vitamin B12) and B12 binding proteins in hypereosinophilic syndromes and secondary eosinophilia. Blood. 1984;63:779-783.
15. Foster B, Schwartz LB, Devouassoux G, Metcalfe DD, Prussin C. Characterization of mast-cell tryptase-expressing peripheral blood cells as basophils. J Allergy Clin Immunol. 2002;109:287-293.
16. Sperr WR, Jordan J, Baghestanian M, et al. Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia. Blood. 2001;98:2200-2209.
17. Valent P, Horny H, Escribano L, et al. Diagnostic criteria and classification of mastocytosis: a consensus proposal. Leuk Res. 2001;25:603-625.
18. Nagata H, Worobec AS, Oh CK, et al. Identification of a point mutation in the catalytic domain of the proto-oncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder. Proc Natl Acad Sci U S A. 1995;92:10560-10564.
19. Rioux JD, Stone VA, Daly MJ, et al. Familial eosinophilia maps to the cytokine gene cluster on human chromosomal region 5q31-q33. Am J Hum Genet. 1998;63:1086-1094.
20. Harley JB, Fauci AS, Gralnick HR. Noncardiovascular findings associated with heart disease in the idiopathic hypereosinophilic syndrome. Am J Cardiol. 1983;52:321-324.
21. Castells MC, Irani AM, Schwartz LB. Evaluation of human peripheral blood leukocytes for mast cell tryptase. J Immunol. 1987;138:2184-2189.
22. Horny HP, Ruck M, Wehrmann M, Kaiserling E. Blood findings in generalized mastocytosis: evidence of frequent simultaneous occurrence of myeloproliferative disorders. Br J Haematol. 1990;76:186-193.
23. Piliponsky AM, Gleich GJ, Bar I, Levi-Schaffer F. Effects of eosinophils on mast cells: a new pathway for the perpetuation of allergic inflammation. Molec Immunol. 2001;38:1369-1372.
24. Ochi HH, Hirani WM, Yuan Q, Friend DS, Austen KF, Boyce JA. T helper cell type 2 cytokine mediated comitogenic responses and CCR3 expression during differentiation of human mast cells in vitro. J Exp Med. 1999;190:267-280.
25. Woo C, Jeong DJ, Yoon S, et al. Eotaxin induces migration of RBL-2H3 mast cells via a Rac-ERK-dependent pathway. Biochem Biophys Res Comm. 2002;298:392-397.
26. De Paulis A, Annunziato F, Di Gioia L, et al. Expression of the chemokine receptor CCR3 on human mast cells. Int Arch Allergy Immunol. 2001;124:146-150.
27. Gordon JR, Burd PR, Galli SJ. Mast cells as a source of multifunctional cytokines. Immunol Today. 1990;11:458-464.
28. Kobayashi H, Gleich GJ, Butterfield JH, Kita H. Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimui. Blood. 2002;99:2214-2220.
29. Patella V, de Crescenzo G, Marino I, et al. Eosinophil granule proteins activate human heart mast cells. J Immunol. 1996;157:1219-1225.
30. Piliponsky AM, Leich GJ, Nagler A, Bar I, Levi-Schaffer F. Non-IgE dependent activation of human lung and cord blood-derived mast cells is induced by eosinophil major basic protein and modulated by the membrane form of stem cell factor. Blood. 2003;101:1898-1904.
31. Pesci A, Majori M, Piccoli ML, et al. Mast cells in bronchiolitis obliterans organizing pneumonia: mast cell hyperplasia and evidence for extracellular release of tryptase. Chest. 1996;110:383-391.
32. Matsunaga Y, Terada T. Mast cell populations in chronic inflammatory hepatobiliary diseases. Liver. 2000;20:152-156.
33. Kondo S, Kagami S, Kido H, Strutz F, Muller GA, Kuroda Y. Role of mast cell tryptase in renal interstitial fibrosis. J Am Soc Nephrol. 2001;12:1668-1676
34. Apa DD, Cayan S, Polar A, Akbay E. Mast cells and fibrosis in testicular biopsies in male infertility. Arch Androl. 2002;48:337-344.
35. Frungieri MB, Weidinger S, Meineke V, Köhn FM Mayerhofer A. Proliferative action of mast-cell tryptase is mediated by PAR2, COX2, prostaglandins, and PPARγ: possible relevance to human fibrotic disorders. Proc Natl Acad Sci U S A. 2002;99:15072-15077.